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Objective: To retrospectively define which histologic characteristics of small-sized hepatocellular carcinomas (HCCs) are 
related to atypical dynamic enhancement on multi-detector computed tomography (MDCT) imaging.
Materials and Methods: Seventy-three patients with 83 HCCs (3 cm or less in diameter) were included in this study. All 
patients underwent 4-phase MDCT imaging and subsequent surgery within eight weeks. Two independent radiologists 
blinded to the histologic findings retrospectively classified the HCCs as either typical (showing increased enhancement on 
arterial phase images followed by washout in late phase images) or atypical lesions demonstrating any other enhancement 
pattern. From the original pathologic reports, various histologic characteristics including gross morphology, nuclear 
histologic grades, presence of capsule formation, and capsule infiltration when a capsule was present, were compared 
among the two groups.
Results: An atypical enhancement pattern was seen in 30 (36.2%) of the 83 HCCs. The mean size of atypical HCCs (1.71 ± 
0.764) was significantly smaller than that of typical HCCs (2.31 ± 0.598, p < 0.001). Atypical HCCs were frequently found to 
be vaguely nodular in gross morphology (n = 13, 43.3%) and to have grade I nuclear grades (n = 17, 56.7%). Capsule 
formation was significantly more common in typical HCCs (p < 0.001). Capsular infiltration was also more common in typical 
HCCs (p = 0.001).
Conclusion: HCCs showing atypical dynamic enhancement on MDCT imaging are usually smaller than typical HCCs, vaguely 
nodular type in gross morphology in most cases, and well-differentiated in nuclear grades, and they lack of capsule 
formation or capsular infiltration.
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INTRODUCTION
The main workflow for the diagnosis of hepatocellular 
carcinomas (HCCs) has changed dramatically over the 
past few decades; from invasive procedures such as an 
angiography or biopsy to noninvasive procedures such as 
either dynamic contrast-enhanced computed tomography 
(CT) or magnetic resonance imaging (MRI) (1). The most 
recent guidelines issued by the American Association for 
the Study of Liver Diseases (AASLD) state that a lesion seen 
in patients with a risk of HCC greater than 1 cm in diameter 
also shows the typical enhancement patterns on dynamic CT 
or MRI, which include arterial hypervascularity and venous 
or delayed phase washout, and can be treated under the 
diagnosis of HCC (2). If the appearance is not typical for a 
HCC, a second imaging study (either CT or MRI) or biopsy is 
necessary (2). 
Of the two modalities, multi-detector CT (MDCT) is the 
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more widely used technique to diagnose HCCs, although 
gadolinium-enhanced dynamic MRI may be superior to MDCT 
(3, 4). CT is however more widespread and has a shorter 
examination time. The typical appearance of a HCC on 
dynamic CT or MRI is increased enhancement on the arterial 
phase (arterial hypervascularity) followed by decreased 
enhancement (washout) of the tumor in the portal venous 
or delayed phases (5). However, some HCCs, especially less 
than 2-3 cm in diameter (6, 7), and well-differentiated ones 
lacking typical hemodynamic changes can make diagnosing 
HCC a challenge (8). However, histologic differences are not 
well known between the HCCs showing typical and atypical 
dynamic imaging features. The purpose of this study was 
to retrospectively compare the histologic characteristics 
of HCCs with typical and atypical dynamic enhancement 
patterns on preoperative MDCT imaging in small HCCs of 3 
cm or less in diameter. 
MATERIALS AND METHODS
Patients
Our institutional review board approved this retrospective 
study and waived the informed consent requirement. 
Surgical resection pathology records from June 2007 to 
February 2010 were reviewed to identify the cases of 
patients with a pathologic HCC diagnosis. Among these 
patients, the study sample was selected on the basis of the 
following inclusion criteria: pathologic diagnoses of HCCs 
measuring 3 cm or less in diameter, available preoperative 
4-phase MDCT scans obtained according to the standard 
protocol for dynamic liver CT, interval between pathologic 
diagnosis and CT of no longer than 8 weeks, and no history 
of previous adjuvant treatment, such as transcatheter 
arterial chemoembolization, percutaneous ethanol injection, 
or radiofrequency ablation. All the patients that underwent 
surgery were non-cirrhotic or have cirrhosis but still have 
well preserved liver function. In our institution, atypically 
enhancing but suspicious lesions for HCC were closely 
followed up or treated with surgical resection because of 
the malignant potential for development to HCC through 
the multistep progression of hepatocarcinogenesis (9).
A total of 83 HCCs in 73 consecutive patients were 
included in the current study. Among the 73 patients, 64 
had one HCC each, eight had two HCCs, and one had three 
HCCs. Among the 83 HCCs, 12 HCCs were 1 cm or less in 
diameter. Three of the 12 HCCs with diameters 1 cm or 
less newly appeared with typical enhancement during 
the surveillance. The remaining 9 HCCs showed atypical 
enhancement, but were resected together during surgery for 
another typical HCC found in the preoperative MDCT. 
Pathological Analysis
In all cases, the pathologic reports including the gross 
and histological analyses, were reviewed. Tumor size, gross 
morphology, tumor necrosis or hemorrhage/peliosis, tumor 
grade, histology type, cell type, fatty change, capsule 
formation (capsule infiltration if a capsule was present), 
portal vein invasion, bile duct invasion, and microvascular 
invasion were reviewed. Tumor size grade was classified 
into three groups: group 1 was 1 cm or less in diameter, 
group 2 was between 1 and 2 cm in diameter, and group 
3 was between 2 and 3 cm in diameter. The tumor grade 
of the HCCs was classified as grade I (well differentiated), 
grade II (moderately differentiated) and grade III (poorly 
differentiated), or IV, according to the nuclear grading 
scheme by Edmondson and Steiner (10). If the histologic 
grade of the tumor consisted of more than two grades, 
the major component of the grade was recorded for the 
analysis. Gross morphology was stratified into vaguely 
nodular, expanding, nodular and perinodular extending, 
multinodular confluent or infiltrative type. The histologic 
types were trabecular, pseudoglandular, scirrhous, compact 
and lymphoid. Cell types were hepatic, clear or giant. 
Fibrous capsule formation was recorded as either present 
(whether complete or partial) or absent. 
CT Techniques
All CT scans were performed with multidetector scanners 
(Somatom Sensation 16 or Sensation 64; Siemens Medical 
Solutions, Forchheim, Germany). All patients received a 2 
mL/kg dose (total volume < 150 mL) of nonionic contrast 
material (Iopromid [Ultravist]; Bayer Schering, Berlin, 
Germany, or iohexol [Omnipaque 300]; Nycomed Amersham, 
GE Healthcare, Milwaukee, WI, USA), intravenously with a 
power injector (EnVisionCT; Medrad, Pittsburgh, PA, USA), 
with a 30-second fixed injection duration. A precontrast 
scan was obtained before the administration of contrast 
media. Using a bolus tracking technique, arterial phase 
imaging was started after an 18-second delay from the time 
100 Hounsfield units of aortic enhancement was attained. 
A 30-second scan delay after arterial phase imaging was 
used for portal venous phase imaging. Equilibrium phase 
imaging was also obtained 150 seconds after the end of 
portal venous phase imaging. The scanning parameters were 
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as follows: collimation, 16 rows x 0.75 mm or 64 rows x 0.6 
mm; gantry rotation speed, 0.5 seconds; section thickness, 
3 mm; image reconstruction increment, 1 mm; 120 kV; and 
effective tube current-time charge, 200-250 mA. 
Image Analysis
The attenuation of HCCs were classified as 
hyperattenuated, isoattenuated, and hypoattenuated, 
compared with the surrounding liver parenchyma on 
the unenhanced phase, arterial phase, portal venous 
phase, and equilibrium phase images. Increased arterial 
enhancement was considered when the tumor showed 
hyperattenuation compared to the surrounding liver 
parenchyma during the arterial phase or the attenuation 
of tumor seen on unenhanced images. On the portal 
venous phase and equilibrium phase images, each lesion 
was subjectively evaluated for the presence of washout. 
Subjective tumor washout was present if the tumor hyper- 
Fig. 1. 43-year-old man with underlying B-viral hepatitis. 
(A) Precontrast, (B) hepatic arterial, (C) portal venous, (D) equilibrium phase images from 4-phase multi-detector CT scan. Hypoattenuating 
lesion (arrow) is seen on precontrast phase image (A). Lesion (arrow) shows increased arterial enhancement on arterial phase image (B) and 
washout of contrast enhancement on portal venous (C) and equilibrium phase images (D). (E) Gross specimen of lesion (arrow). Histologic 
examination demonstrated poorly differentiated (nuclear grade III) hepatocellular carcinoma of expanding type gross morphology with partial 
capsule formation and infiltration.
A
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or iso-attenuating to the liver on an arterial phase image 
subsequently appeared to be hypoattenuated compared to 
the surrounding liver parenchyma on the portal venous or 
equilibrium phase images. Two independent radiologists 
blinded to the histologic findings retrospectively stratified 
the HCCs into either typical or atypical HCCs. Disagreements 
in interpretation were resolved by consensus. Typical HCCs 
were defined as lesions that showed increased arterial 
enhancement on arterial phase images followed by washout 
in late phase images (Fig. 1). Atypical HCCs were defined 
as lesions that did not show a typical enhancement pattern 
(Fig. 2). After classifying HCCs as typical and atypical, 
the gross and histologic characteristics of the HCCs were 
compared between the two groups.
Fig. 2. 49-year-old man with B-viral liver cirrhosis. 
(A) Precontrast, (B) hepatic arterial, (C) portal venous, (D) equilibrium phase images from 4-phase multi-detector CT scan. On precontrast (A) 
and arterial phase (B), lesion (arrow) showed isoattenuation compared to surrounding parenchyma. On portal venous (C) and equilibrium phase 
(D), lesion (arrow) shows hypoattenuation compared to surrounding parenchyma. (E) Gross specimen of lesion (arrow). Histologic examination 
showed well-differentiated (nuclear grade I) hepatocellular carcinoma of vaguely nodular type in gross morphology without capsule formation.
A
D
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E
C
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Statistical Analysis
An independent t test was used to compare age and mean 
difference in tumor size between the two groups. A chi-
square test was used to compare sex differences between 
two groups. The chi-square test or Fisher’s exact test was 
used to compare categorical data according to the expected 
frequency in each cell of the tables. p values of less than 
0.05 were considered statistically significant. All statistical 
analyses were performed using a statistical software (SPSS, 
version 17.0.1, SPSS, Chicago, IL, USA). 
RESULTS
A total of 83 HCCs (2.09 ± 0.71 cm in diameter, 0.4 cm 
to 3.0 cm in range) in 73 patients (54.7 ± 10.5 years old, 
60 men and 13 women) were included in this study. A total 
of 69 (94%) out of the 73 patients had liver cirrhosis. Most 
of the patients had cirrhosis caused by a hepatitis B virus 
infection (n = 60; 82.2%), and the rest had cirrhosis caused 
by a hepatitis C virus infection (n = 6; 8.2%) or alcohol (n 
= 3; 4.1%).
Fifty-three (63.8%) HCCs were classified as typical, 
whereas 30 (36.2%) were classified as atypical HCCs (Table 
1). Sixteen of the 30 atypical HCCs show delayed phase 
washout without arterial enhancement. Moreover, nine 
of the 30 atypical HCCs show arterial enhancement only 
without delayed phase washout. Five of the 30 atypical 
HCCs showed neither arterial enhancement nor delayed 
phase washout.
The mean size of the atypical HCCs (1.7 ± 0.7) was 
significantly smaller than that of the typical HCCs (2.3 ± 0.6, 
p < 0.001). According to the criteria of 2 cm in diameter, 40 
(48.2%) HCCs were 2 cm or less in diameter and 43 (51.8%) 
HCCs were between 2 cm and 3 cm in diameter. Among 40 
HCCs 2 cm or less than 2 cm in diameter, 19 (47.5%) were 
typical HCCs and 21 (52.5%) were atypical HCCs. However, 
among the 43 HCCs between 2 cm and 3 cm in diameter, 34 
(79.1%) HCCs were typical HCC and 9 (20.9%) HCCs were 
atypical HCCs. Sex and age were not significantly different 
between the typical and atypical HCCs.
Gross morphology of the vaguely nodular type was 
significantly more common in atypical HCCs (p < 0.001). 
However, the expanding type was significantly more 
common in typical HCCs (p = 0.001). As for Edmondson-
Steiner nuclear histologic grades, well-differentiated (Grade 
I) HCCs were more common in atypical HCCs (p < 0.001), 
but moderate (grade II) or poorly differentiated (grade III) 
HCCs were significantly more common in typical HCCs (p < 
0.001). Capsule formation was significantly more common 
than for typical HCCs (p < 0.001). Capsular infiltration was 
more common in typical HCCs (p = 0.001).
Other pathologic characteristics including tumor necrosis, 
hemorrhage/peliosis, histologic types, cell types, fatty 
change, portal vein invasion, bile duct invasion and 
microvascular invasion, showed no significant differences 
between the atypical and typical HCCs.
DISCUSSION
Our results showed that the various histologic 
characteristics of HCCs are related to atypical dynamic 
enhancement patterns on contrast-enhanced dynamic CT. 
In our study, 63.8% (50/83) of HCCs showed the 
typical enhancement pattern of HCCs, including 
increased enhancement on the arterial phase and 
washout on portal venous or delayed phase images (11). 
This typical enhancement pattern is consistent with 
hepatocarcinogenesis, which causes vascular changes 
toward a predominantly hepatic arterial supply with a lack 
of portal venous supply (12-14). However, the predominant 
enhancement patterns of HCC during the arterial and 
portal venous phases were significantly different based on 
tumor size and cellular differentiation of the tumor. In our 
study, the mean size of HCCs showing typical enhancement 
patterns was larger than that of HCCs with atypical 
enhancement patterns (p < 0.001). In addition, there was 
a significantly higher proportion of typical HCCs among 
HCCs between 2 cm and 3 cm in diameter (p = 0.0057). 
These results are similar to those of previous studies (15-
17). Also, in our study, well-differentiated HCCs were more 
common among atypical HCCs (p < 0.001), while moderate 
and poorly differentiated HCCs were significantly more 
common among typical HCCs (p < 0.001). A previous study 
that evaluated the relationship of the vascularization of 
small HCC and the cellular differentiation has shown that 
abnormal arterial supply within a nodule increases as 
the grade of the malignancy increases, while, the normal 
hepatic arterial and portal venous supply to the nodule 
gradually decreases (18). Another study reported that well-
differentiated and small HCCs more often showed various 
atypical CT enhancement features (19, 20).
Early HCCs showed the typical dynamic enhancement 
pattern less often than more advanced lesions in our study. 
Thirteen (43.3%) atypical lesions were vaguely nodular in 
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Table 1. Histologic and Clinical Characteristics of Atypical and Typical Hepatocellular Carcinoma
Atypical (n = 30) Typical (n = 53) P
Mean age = 55 ± 10.6 / M : F = 69 : 14 (n = 83)
Sex (M/F) 25 / 5 44 / 9 0.971
Age 53 ± 10.2 56 ± 10.8 0.295
Size grade
Mean 1.71 ± 0.764 2.31 ± 0.598 < 0.001
1 cm or less   9 (30.0%) 3 (5.7%) 0.001
< 1 - 2 cm 12 (40.0%) 16 (30.2%)
< 2 - 3 cm   9 (30.0%) 34 (64.2%)
Gross type
Expanding   5 (16.7%) 28 (52.8%) 0.001
Multinodular confluent   9 (30.0%) 19 (35.8%) 0.636
Nodular/Perinodal extension 1 (3.3%) 5 (9.4%) 0.411
Vaguely nodular 13 (43.3%) 1 (1.9%) < 0.001
Infiltrative 2 (6.7%) 0 (0.0%) 0.128
Tumor necrosis (available n = 82 )
No 25 (86.2%) 40 (75.5%) 0.252
Yes   4 (13.8%) 13 (24.5%)
Hemorrhage/Peliosis (available n = 82 )
No 27 (93.1%) 38 (71.7%) 0.022
Yes 2 (6.9%) 15 (28.3%)
Grade (major)
1.0 17 (56.7%)  6 (11.3%) < 0.001
2.0 10 (33.3%) 40 (75.4%)
3.0   3 (10.0%)  7 (13.3%)
Grade (worst)
1.0 16 (53.3%)  1 (1.8 %) < 0.001
2.0   8 (26.7%) 26 (49.1%)
3.0   6 (20.0%) 26 (49.1%)
Histology type
Trabecular   30 (100.0%)   53 (100.0%)
Pseudoglandular   8 (26.7%) 18 (34.0%) 0.624
Scirrhous 1 (3.3%) 3 (5.7%) 1.000
Compact   3 (10.0%)   7 (13.2%) 0.741
Lymphoid 0 4 (7.5%) 0.291
Cell type
Hepatic 29 (96.7%)   53 (100.0%) 0.361
Clear 11 (36.7%) 20 (37.7%) 1.000
Giant 1 (3.3%) 4 (7.5%) 0.649
Fatty change (available n = 82)
No 14 (48.3%) 32 (60.4%) 0.291
Yes 15 (51.7%) 21 (39.6%) 
Capsule formation (available n = 82)
No 19 (65.5%)   8 (15.1%) < 0.001
Yes 10 (34.5%) 45 (84.9%)
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gross morphology, and 17 (56.7%) atypical lesions were 
well-differentiated by tumor grade. These characteristics are 
compatible with early HCCs, defined as well-differentiated 
lesions that are usually less than 2 cm in diameter, vaguely 
nodular in gross morphology, not showing the capsule 
formation, and usual hypovascularity (21).
A fibrous capsule that is known to be frequently observed 
around a tumor during the growth of HCCs was more 
frequently seen in typical HCCs in our study. And our study 
also showed that moderate and poorly differentiated HCCs 
were significantly more common among typical HCCs (p < 
0.001). The capsule is formed by a host of mesenchymal 
cells and not by HCC cells. In addition, the capsule 
formation may result from interactions between the tumor 
and host liver and interfere the growth and invasion of 
HCCs (22). This is supported by clinical evidence that the 
prognosis of patients with a HCC having capsule is better 
than for those without capsule (23-26) Therefore progressed 
HCC with typical enhancement pattern in spite of its small 
size more often forms capsule than indolent early HCC with 
atypical enhancement pattern in our study.
There are limitations to our study. First, our study is 
retrospective and we included surgically confirmed HCCs 
to compare the dynamic imaging patterns with histologic 
characteristics. Therefore, small HCCs that were diagnosed 
based on the presence of a typical dynamic pattern, which 
was subsequently treated by locoregional. This might have 
increased the proportion of atypical lesions in our study. 
Second, the definitions we used for increased arterial 
enhancement and presence of washout may differ from 
those used by other investigators. We determined the 
presence of increased arterial enhancement by comparing 
it with precontrast images; some investigators may 
determine the presence of increased arterial enhancement 
on the arterial phase images alone. However, we believe 
that increased arterial enhancement can be correctly 
assessed by referring to precontrast images because some 
lesions showing hypoattenuation on precontrast images 
may show isoattenuation on arterial phase images even 
though they have increased the arterial vascularity within 
the lesions. We considered washout to be present when a 
lesion showed hypointensity relative to the surrounding 
liver on late phase images. Some radiologists could argue 
that washout may not be present when a lesion does not 
show increased arterial enhancement. However, we thought 
that such comparison would cause greater interobserver 
variability. Third, atypical HCCs are consisted of diverse 
subgroups according to the presence of the arterial 
enhancement or delayed phase washout. We considered 
atypical HCCs as lesions that did not show a typical 
enhancement pattern and was not divided into subgroups 
in the analysis process. Further studies are needed to define 
the characteristics of diverse subgroups of atypical HCCs. 
Lastly, we did not analyze how many hypovascular lesions 
transform to hypervascular lesions. A recent study revealed 
that hypoattenuating hepatic nodular lesions in chronic 
liver disease depicted on dynamic CT has high malignant 
potential (27). There are chances that atypically enhancing 
HCCs progressed to typically enhancing HCCs according 
to the hepatocarcinogenesis, but we analyzed only the 
preoperative CT scan of just before the surgery, not serial CT 
scans.
We conclude that various histologic characteristics of 
HCC are associated with atypical dynamic enhancement on 
contrast-enhanced dynamic CT images. HCCs with atypical 
enhancement patterns tend to be smaller than HCCs with a 
Table 1. Histologic and Clinical Characteristics of Atypical and Typical Hepatocellular Carcinoma
Atypical (n = 30) Typical (n = 53) P
Capsule infiltration (available n = 82)
No 22 (75.9%) 19 (35.8%) 0.001
Yes   7 (24.1%) 34 (64.2%)
Portal vein invasion (available n = 78)
No 24 (96.0%) 52 (98.1%) 0.541
Yes 1 (4.0%) 1 (1.9%)
Bile duct invasion (available n = 78)
No 24 (96.0%) 51 (96.2%) 1.000
Yes 1 (4.0%) 2 (3.8%)
Microvascular invasion (available n = 78)
No 17 (68.0%) 29 (54.7%) 0.266
Yes   8 (32.0%) 24 (45.3%)
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typical enhancement pattern and are vaguely a nodular type 
in gross morphology and well-differentiated in histologic 
grades. Capsule formation and capsular infiltration are 
significantly more common in typical HCCs. Awareness of 
atypical enhancement patterns in small HCCs and their 
histologic implications may guide patient management.
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